What this ad does well
The open palm is a calm, human way to show scale: the pill looks small and easy, which is exactly the feeling "gentler" is meant to carry. The headline names the category (weight loss) as well as the promise, so the ad makes sense to someone who's never heard of a microdose plan. The callouts sit right beside the pill, so the details are attached to the product instead of floating in a list.
What's missing
Like the other microdose statics, it skips the moment that would make a viewer feel seen: the frustration of a scale that won't move or the hesitation about starting a stronger treatment. If you make one like this, lead with a line the customer would say to herself (the page's own answer options, like losing a few stubborn pounds, are a good source) and keep the palm shot as the answer. Adding the $39 first month to the bottom bar would also give the tap a reason now.
Beat by beat
- Image
An open palm holds one small pill with a bowl blurred behind, two callouts beside it, and a bottom bar reading weight loss by hers and Take the quiz.The scale of the pill in a hand makes the start look small and manageable.
- Headline
"A gentler way to start weight loss" on the image, with "A gentler start" as the ad headline.It names both the category and the promise, so new viewers know what this is.
- Copy
The copy describes the Wegovy Pill Microdose Plan as built for those with less weight to lose, with a 1.5mg starting dose and a $39 first month.It adds the audience and the entry price.
The offer
The copy lists a membership at $39 for the first month, then $149/month, and its fine print says the price covers the membership only, doesn't include or guarantee a prescription, and that microdosing is off-label and lower doses are unstudied for weight loss. Hers frames it as a low-commitment way in rather than a discount.
Where it sends people
The click lands on a dedicated lower-dose plan page, one of 9 ads in the Fluid library that point there, which sits between a focused landing page and a quiz. Under a "Wegovy Pill Microdosing Plan now available with Hers" bar, the hero headline reads "Built for modest goals" beside a short tap-to-answer intake ("What brings you here today?" with answers like losing a few stubborn pounds), followed by more soft questions, a "We've got range" row of treatment cards with starting prices, a membership checklist and an FAQ that includes why to start on a lower dose. The ad's "Take the quiz" bar sets up the page's intake, and the page's soft-entry answers (like wanting to ease into it) speak the same language as this ad's headline.
The page it sends people to: How Hers gives its lower-dose Wegovy plan its own landing page
Hers's landing page for the Wegovy Pill Microdosing Plan leads with "Built for modest goals", then asks three soft prompts about why the visitor is here, how they want to approach it and how they want to feel, before a plan carousel, membership perks and a plan-specific FAQ. 9 ads in the Fluid library send people here, all launch ads.
How the page is built
- 01
Announcement bar and headerA green bar announces that the Wegovy Pill Microdosing Plan is now available with Hers, above a logo-only header, so the launch news is the first thing a visitor reads.
- 02
Hero with first promptA portrait with a line-graph overlay and a pill product card carries the modest-goals headline, beside a three-step indicator and the question "What brings you here today?" with three answers in the visitor's words.
- 03
Approach promptA second question asks how the visitor wants to approach weight loss, answering "will this fit how I want to do it?" with three pill choices.
- 04
Feeling promptA third question asks how the visitor wants to feel, closing the intake on the outcome they picture rather than a medical detail.
- 05
Plan carouselAn FSA and HSA eligible tag and a Get started today button sit above cards for the Wegovy Pill, the Microdosing Plan, the Wegovy Pen and Ozempic, each with a "from" monthly price, a membership-required note and a safety link.
- 06
Pricing fine printSmall print under the cards explains that prices cover medication only and that a separate membership is required, answering the cost question in full for anyone who reads it.
- 07
MembershipA four-photo collage over five check rows (treatment plan, provider messaging, member community, partner discounts, smart scale) answers "what comes with the membership?"
- 08
FAQSeven accordions cover the membership, its cost, the difference from the full-dose pill, why start lower, switching later, state availability and insurance, with a Get started today button beside them.
The first fixes we would make
- There's no proof on the page: no member stories, no provider explaining who the lower-dose plan is for, nothing beyond the collage photos. Add a short provider note or a few member stories from people with modest goals right after the plan carousel, attributed and with the usual disclaimers, so the visitor sees someone like them before they commit.
- The page's own FAQ asks how the Microdosing Plan differs from the Wegovy Pill, which tells you visitors need that comparison, yet the carousel shows the two as similar-looking cards. Put a small side-by-side table of the two plans (dose approach, monthly price, who each is for) above the FAQ, so the answer is visible instead of hidden in an accordion.
Read the full breakdown of this page
Three hooks you could test
- Lead with the uncomfortable problem. “Those last few pounds won't budge? Start smaller.”
- Turn the benefit into a picture people get in a second. “Your first step fits in the palm of your hand.”
- Sell the outcome. “Ease into it, and feel like yourself again.”
What to borrow for your brand
- Show the product in an open hand to communicate size and ease without a word of copy.
- Attach short callouts directly to the product rather than listing benefits in a block of text.
- Pull headline lines from the answer options on your own quiz, since those are already written in the customer's words.
One of 125 Hers ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.